Literature DB >> 27105634

Declarations, accusations and judgement: examining conflict of interest discourses as performative speech-acts.

Christopher Mayes1, Wendy Lipworth2, Ian Kerridge2.   

Abstract

Concerns over conflicts of interest (COI) in academic research and medical practice continue to provoke a great deal of discussion. What is most obvious in this discourse is that when COIs are declared, or perceived to exist in others, there is a focus on both the descriptive question of whether there is a COI and, subsequently, the normative question of whether it is good, bad or neutral. We contend, however, that in addition to the descriptive and normative, COI declarations and accusations can be understood as performatives. In this article, we apply J.L. Austin's performative speech-act theory to COI discourses and illustrate how this works using a contemporary case study of COI in biomedical publishing. We argue that using Austin's theory of performative speech-acts serves to highlight the social arrangements and role of authorities in COI discourse and so provides a rich framework to examine declarations, accusations and judgements of COI that often arise in the context of biomedical research and practice.

Entities:  

Keywords:  Conflicts of interest; Discourse analysis; J.L. Austin; Research ethics

Mesh:

Year:  2016        PMID: 27105634     DOI: 10.1007/s11019-016-9703-8

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  9 in total

1.  Novel melatonin-based treatments for major depression.

Authors:  Corrado Barbui; Andrea Cipriani
Journal:  Lancet       Date:  2012-01-21       Impact factor: 79.321

2.  Novel melatonin-based treatments for major depression.

Authors:  Jon Jureidini; Melissa Raven
Journal:  Lancet       Date:  2012-01-21       Impact factor: 79.321

3.  Novel melatonin-based treatments for major depression.

Authors:  Bernard J Carroll
Journal:  Lancet       Date:  2012-01-21       Impact factor: 79.321

4.  Novel melatonin-based treatments for major depression.

Authors:  Celia Lloret-Linares; Jean-François Bergmann; Stéphane Mouly
Journal:  Lancet       Date:  2012-01-21       Impact factor: 79.321

5.  Novel melatonin-based treatments for major depression.

Authors:  Marc Serfaty; Peter W Raven
Journal:  Lancet       Date:  2012-01-21       Impact factor: 79.321

6.  Understanding financial conflicts of interest.

Authors:  D F Thompson
Journal:  N Engl J Med       Date:  1993-08-19       Impact factor: 91.245

7.  Be said to be influenced by personal prejudice (six letters).

Authors:  Christopher J Ryan
Journal:  Aust N Z J Psychiatry       Date:  2012-06       Impact factor: 5.744

8.  Taking financial relationships into account when assessing research.

Authors:  David B Resnik; Kevin C Elliott
Journal:  Account Res       Date:  2013       Impact factor: 2.622

Review 9.  Novel melatonin-based therapies: potential advances in the treatment of major depression.

Authors:  Ian B Hickie; Naomi L Rogers
Journal:  Lancet       Date:  2011-05-17       Impact factor: 79.321

  9 in total
  1 in total

1.  (Re)disclosing physician financial interests: rebuilding trust or making unreasonable burdens on physicians?

Authors:  Daniel Sperling
Journal:  Med Health Care Philos       Date:  2017-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.